In Brief: Elan Naprelan
Executive Summary
Elan Naprelan: Wyeth-Ayerst will market once-daily formulation of naproxen sodium in the U.S., Canada and Mexico under agreement disclosed July 17. Naproxen innovator Syntex previously had been Elan's partner for the drug. An NDA for Naprelan is pending at FDA...
Elan Naprelan: Wyeth-Ayerst will market once-daily formulation of naproxen sodium in the U.S., Canada and Mexico under agreement disclosed July 17. Naproxen innovator Syntex previously had been Elan's partner for the drug. An NDA for Naprelan is pending at FDA.... |